Gemith Pharma Private Limited
About Gemith Pharma Private Limited
Data last updated:
Gemith Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 19 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2015PTC207498.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sourav Mukherjee and Indrajit Haldar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 228/A Talpukur Baghajatin, Kolkata, West Bengal, India – 700086.
As per the financials filed for FY 2024, the company reported a revenue of ₹31,450, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2,170 (net margin 6.9%) and EBITDA of ₹3,220 (EBITDA margin 10.2%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address228/A Talpukur Baghajatin, Kolkata, West Bengal, India – 700086
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gemith Pharma Private Limited
The main business activity of Gemith Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gemith Pharma Private Limited FY 2025 filings available
Gemith Pharma Private Limited reported revenue of ₹31,450 (up 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Gemith Pharma Private Limited
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gemith Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3,220 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2,170 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gemith Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gemith Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gemith Pharma Private Limited
Gemith Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maven Meditech Private Limited | ₹31,548 (FY 2017) | •••• | •••• | 10.0% | •••• | Lucknow, Uttar Pradesh, India |
| Three Eyes Marketing & Sales India Private Limited | ₹31,510 (FY 2018) | •••• | •••• | 118.0% | •••• | Mumbai, Maharashtra, India |
| Ishvi Wafers Private Limited | ₹31,500 (FY 2023) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Varalika Marketing Limited | ₹31,500 (FY 2025) | •••• | •••• | 37.0% | •••• | Delhi, India |
| Essential Securities Private Limited | ₹31,468 (FY 2025) | •••• | •••• | -58.0% | •••• | Delhi, India |
| Gemith Pharma Private Limited this company | ₹31,450 (FY 2024) | •••• | •••• | 3.0% | •••• | Kolkata, West Bengal, India |
| Starburst Internet (OPC) Private Limited | ₹31,447 (FY 2018) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Dashanan Industries Private Limited | ₹31,439 (FY 2024) | •••• | •••• | -97.0% | •••• | Patna, Bihar, India |
| Mastech Devices Private Limited | ₹31,415 (FY 2018) | •••• | •••• | 307.0% | •••• | Delhi, India |
| Chidanand Enterprises Private Limited | ₹31,415 (FY 2016) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India | |
| Alampata Agro Private Limited | ₹31,320 (FY 2025) | •••• | •••• | 28.0% | •••• | Gurugram, Haryana, India |
Peers are the five companies nearest above and the five nearest below Gemith Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gemith Pharma Private Limited
Gemith Pharma Private Limited is audited by BIPULKUMARSARKAR for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BIPULKUMARSARKAR | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gemith Pharma Private Limited
Gemith Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sourav Mukherjee | Director | 19 Aug 2015 | 11 Years 1 Months | Current |
| Indrajit Haldar | Additional Director | 07 Aug 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Gemith Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gemith Pharma Private Limited
Gemith Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gemith Pharma Private Limited
Employment history and EPFO contributions of people linked to Gemith Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gemith Pharma Private Limited
Gemith Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Kamalendu Bhattacharjee ceased to be Additional Director on 09 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Gemith Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gemith Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gemith Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gemith Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gemith Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gemith Pharma Private Limited
Gemith Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in wholesale, within the trading industry. It was incorporated on 19 August 2015 (11+ years old) and is registered under CIN U24100WB2015PTC207498.
Gemith Pharma reported revenue of ₹31,450 for FY 2024 (up 3% YoY).
Gemith Pharma has 2 current directors:
- Sourav Mukherjee - Director
- Indrajit Haldar - Additional Director
Gemith Pharma reported a net profit of ₹2,170 (net margin 6.9%) and EBITDA of ₹3,220 (EBITDA margin 10.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gemith Pharma is 17% over three years and -7% over five years. In the latest year (FY 2024) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Gemith Pharma is U24100WB2015PTC207498. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gemith Pharma was incorporated on 19 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Gemith Pharma by revenue are Maven Meditech Private Limited, Three Eyes Marketing & Sales India Private Limited, Ishvi Wafers Private Limited, Varalika Marketing Limited, Essential Securities Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Kamalendu Bhattacharjee ceased to be Additional Director on 09 Aug 2024. Indrajit Haldar was appointed as Additional Director on 07 Aug 2024. Dipa Mukherjee Bhattacharjee ceased to be Director on 27 Aug 2021. Gemith Pharma has 4 board changes on record in total.
The registered office of Gemith Pharma is at 228A Talpukur Baghajatin, Kolkata, West Bengal, India – 700086.
Gemith Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.